Neuroprogression happens.

Psychol Med

Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain.

Published: September 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536099PMC
http://dx.doi.org/10.1017/S0033291724002149DOI Listing

Publication Analysis

Top Keywords

neuroprogression
4
neuroprogression
1

Similar Publications

Objective: Around 30% of people with schizophrenia are refractory to antipsychotic treatment (treatment-resistant schizophrenia). Abnormal structural neuroimaging findings, in particular volume and thickness reductions, are often described in schizophrenia. Novel biomarkers of active brain pathology such as neurofilament light chain protein are now expected to improve current understanding of psychiatric disorders, including schizophrenia.

View Article and Find Full Text PDF

Increased structural covariance of cortical measures in individuals with an at-risk mental state.

Prog Neuropsychopharmacol Biol Psychiatry

January 2025

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama city, Toyama 930-0194, Japan; Research Center for Idling Brain Science, University of Toyama, 2630 Sugitani, Toyama city, Toyama 930-0194, Japan.

An anomalous pattern of structural covariance has been reported in schizophrenia, which has been suggested to represent connectome changes during brain maturation and neuroprogressive processes. It remains unclear whether similar differences exist in a clinical high-risk state for psychosis, and if they are associated with a prodromal phenotype and/or later psychosis onset. This multicenter magnetic resonance imaging study cross-sectionally examined structural covariance in a large at-risk mental state (ARMS) sample with different outcomes.

View Article and Find Full Text PDF

Claudin-5 and occludin levels in patients with psychiatric disorders - A systematic review.

Brain Behav Immun

January 2025

Department of Psychiatry, University of Toronto, Toronto, Canada; Centre for Addiction and Mental Health, Toronto, Canada; Poul Hansen Family Centre for Depression, Centre of Mental Health, University Health Network, Toronto, Canada. Electronic address:

Background: Recent research has underscored the critical role of blood-brain barrier (BBB) integrity in psychiatric disorders, highlighting disruptions in tight junction (TJ) proteins, specifically claudin-5 and occludin. These proteins are pivotal in maintaining the BBB's selective permeability, which is essential forbrain homeostasis. Altered levels of the TJ proteins have been observed in various psychiatric conditions, suggesting potential as biomarkers for the pathophysiology of these disorders.

View Article and Find Full Text PDF

Symptom management for people with advanced dementia who are receiving end of life care.

Curr Opin Support Palliat Care

December 2024

University of Glasgow, School of Medicine, Dentistry and Nursing, Glasgow, UK.

Article Synopsis
  • This review examines current research on managing symptoms for individuals with advanced dementia, particularly in their final year of life, and discusses the challenges faced by palliative care specialists.
  • Recent studies reveal that advanced dementia patients often have unmet needs for pain, breathlessness, and psychological support, resulting in subpar care due to their unpredictable illness progression.
  • To improve the quality of life for these patients, the review suggests better training for caregivers, enhanced teamwork among healthcare providers, and more integrated care approaches in both home and institutional settings.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!